CD274 and non-small cell lung carcinoma: Similar results were also reported by Abdo et al. in a comparative evaluation of PD-L1 in NSCLC patients showing good agreement rates on PD-L1 positivity (TPS ≥ 1%) and high PD-L1 expression (TPS ≥ 50%) [47].